1423 related articles for article (PubMed ID: 26561804)
1. Mycophenolate Mofetil Modulates Differentiation of Th1/Th2 and the Secretion of Cytokines in an Active Crohn's Disease Mouse Model.
Lv QK; Liu JX; Li SN; Gao YJ; Lv Y; Xu ZP; Huang BX; Xu SY; Yang DX; Zeng YL; Liu DF; Wang W
Int J Mol Sci; 2015 Nov; 16(11):26654-66. PubMed ID: 26561804
[TBL] [Abstract][Full Text] [Related]
2. Effect of recombinant serine protease from adult stage of Trichinella spiralis on TNBS-induced experimental colitis in mice.
Pang J; Ding J; Zhang L; Zhang Y; Yang Y; Bai X; Liu X; Jin X; Guo H; Yang Y; Liu M
Int Immunopharmacol; 2020 Sep; 86():106699. PubMed ID: 32570037
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP
Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil promotes down-regulation of expanded B cells and production of TNF-alpha in an experimental murine model of colitis.
Lee J; Kim MS; Kim EY; Park HJ; Chang CY; Park KS; Jung DY; Kwon CH; Joh JW; Kim SJ
Cytokine; 2008 Oct; 44(1):49-56. PubMed ID: 18667332
[TBL] [Abstract][Full Text] [Related]
5. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.
Daniel C; Sartory NA; Zahn N; Radeke HH; Stein JM
J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375
[TBL] [Abstract][Full Text] [Related]
6. Curcumin regulated shift from Th1 to Th2 in trinitrobenzene sulphonic acid-induced chronic colitis.
Zhang M; Deng CS; Zheng JJ; Xia J
Acta Pharmacol Sin; 2006 Aug; 27(8):1071-7. PubMed ID: 16867261
[TBL] [Abstract][Full Text] [Related]
7. All-trans retinoic acid ameliorates trinitrobenzene sulfonic acid-induced colitis by shifting Th1 to Th2 profile.
Bai A; Lu N; Zeng H; Li Z; Zhou X; Chen J; Liu P; Peng Z; Guo Y
J Interferon Cytokine Res; 2010 Jun; 30(6):399-406. PubMed ID: 20187766
[TBL] [Abstract][Full Text] [Related]
8. Oridonin derivative ameliorates experimental colitis by inhibiting activated T-cells and translocation of nuclear factor-kappa B.
Liu QQ; Wang HL; Chen K; Wang SB; Xu Y; Ye Q; Sun YW
J Dig Dis; 2016 Feb; 17(2):104-12. PubMed ID: 26718746
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Adipose-Derived and Bone Marrow Mesenchymal Stromal Cells in a Murine Model of Crohn's Disease.
Xie M; Qin H; Luo Q; He X; He X; Lan P; Lian L
Dig Dis Sci; 2017 Jan; 62(1):115-123. PubMed ID: 27107864
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cells treated by Trichinella spiralis muscle larval excretory/secretory products alleviate TNBS-induced colitis in mice.
Jin X; Yang Y; Bai X; Shi H; Zhang W; Zhang Z; Jia W; Lin J; Liu M; Liu X
Int Immunopharmacol; 2019 May; 70():378-386. PubMed ID: 30852293
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses.
Chen QQ; Yan L; Wang CZ; Wang WH; Shi H; Su BB; Zeng QH; Du HT; Wan J
World J Gastroenterol; 2013 Aug; 19(29):4702-17. PubMed ID: 23922467
[TBL] [Abstract][Full Text] [Related]
12. N-(3', 4'-dimethoxycinnamonyl) anthranilic acid alleviated experimental colitis by inhibiting autoimmune response and inducing CD4+ CD25+ regulatory T cells production.
Wen Q; Zhou L; Chen H; Zhang Y
J Gastroenterol Hepatol; 2013 Aug; 28(8):1330-8. PubMed ID: 23663055
[TBL] [Abstract][Full Text] [Related]
13. [Diosmetin regulates intestinal immune balance by inhibiting PI3K/AKT signaling to relieve 2, 4, 6-trinitrobenzene sulfonic acid-induced Crohn's disease-like colitis in mice].
Yang Z; Zhao T; Cheng Y; Zhou Y; Li Y; Wang X; Zhang X; Zuo L; Ge S
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):474-482. PubMed ID: 37087594
[TBL] [Abstract][Full Text] [Related]
14. Lactosucrose attenuates intestinal inflammation by promoting Th2 cytokine production and enhancing CD86 expression in colitic rats.
Zhou Y; Ruan Z; Zhou X; Huang X; Li H; Wang L; Zhang C; Deng Z; Wu G; Yin Y
Biosci Biotechnol Biochem; 2015; 79(4):643-51. PubMed ID: 25522686
[TBL] [Abstract][Full Text] [Related]
15. Evidence for the critical role of interleukin-12 but not interferon-gamma in the pathogenesis of experimental colitis in mice.
Tozawa K; Hanai H; Sugimoto K; Baba S; Sugimura H; Aoshi T; Uchijima M; Nagata T; Koide Y
J Gastroenterol Hepatol; 2003 May; 18(5):578-87. PubMed ID: 12702051
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of helminth soluble proteins in TNBS-induced colitis in mice.
Ruyssers NE; De Winter BY; De Man JG; Loukas A; Pearson MS; Weinstock JV; Van den Bossche RM; Martinet W; Pelckmans PA; Moreels TG
Inflamm Bowel Dis; 2009 Apr; 15(4):491-500. PubMed ID: 19023900
[TBL] [Abstract][Full Text] [Related]
17. Peptide YY 3-36 attenuates trinitrobenzene sulfonic acid-induced colitis in mice by modulating Th1/Th2 differentiation.
Li Z; Kuang X; Chen T; Shen T; Wu J
Bioengineered; 2022 Apr; 13(4):10144-10158. PubMed ID: 35443853
[TBL] [Abstract][Full Text] [Related]
18. Cytokine expression and the role of Th17 cells in a mouse model of colitis.
He Y; Lin LJ; Zheng CQ; Jin Y; Lin Y
Mol Med Rep; 2012 Dec; 6(6):1438-42. PubMed ID: 23027085
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of recombinant cystatin from Schistosoma japonicum in TNBS-induced experimental colitis of mice.
Wang S; Xie Y; Yang X; Wang X; Yan K; Zhong Z; Wang X; Xu Y; Zhang Y; Liu F; Shen J
Parasit Vectors; 2016 Jan; 9():6. PubMed ID: 26728323
[TBL] [Abstract][Full Text] [Related]
20. Cholera toxin subunit B inhibits IL-12 and IFN-{gamma} production and signaling in experimental colitis and Crohn's disease.
Coccia EM; Remoli ME; Di Giacinto C; Del Zotto B; Giacomini E; Monteleone G; Boirivant M
Gut; 2005 Nov; 54(11):1558-64. PubMed ID: 16105891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
